An Open Protocol for the Compassionate Use of Thalidomide

PHASE1/PHASE2CompletedINTERVENTIONAL

Enrollment

250

Participants

Timeline

Start Date

September 30, 1998

Study Completion Date

May 31, 2005

Conditions

Multiple Myeloma

Interventions

DRUG

Thalidomide

Trial Locations (1)

University of Arkansas for Medical Sciences/MIRT, Little Rock

All Listed Sponsors

lead

University of Arkansas

OTHER

NCT00081757 - An Open Protocol for the Compassionate Use of Thalidomide | Biotech Hunter | Biotech Hunter